Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$209.01 - $232.56 $112,865 - $125,582
540 Added 57.08%
1,486 $324,000
Q4 2023

Jan 31, 2024

BUY
$197.69 - $227.29 $18,780 - $21,592
95 Added 11.16%
946 $215,000
Q2 2023

Jul 28, 2023

BUY
$211.93 - $241.33 $1,059 - $1,206
5 Added 0.59%
851 $205,000
Q1 2023

Apr 26, 2023

BUY
$213.32 - $257.83 $27,304 - $33,002
128 Added 17.83%
846 $194,000
Q4 2022

Jan 24, 2023

BUY
$203.72 - $248.97 $7,537 - $9,211
37 Added 5.43%
718 $0
Q3 2022

Nov 10, 2022

SELL
$204.81 - $262.19 $1,638 - $2,097
-8 Reduced 1.16%
681 $139,000
Q2 2022

Aug 01, 2022

BUY
$213.86 - $277.87 $96,664 - $125,597
452 Added 190.72%
689 $161,000
Q1 2022

Apr 21, 2022

BUY
$259.82 - $298.18 $1,818 - $2,087
7 Added 3.04%
237 $62,000
Q4 2021

Jan 18, 2022

BUY
$271.6 - $314.21 $4,617 - $5,341
17 Added 7.98%
230 $72,000
Q1 2021

Apr 28, 2021

BUY
$204.88 - $255.03 $1,639 - $2,040
8 Added 3.9%
213 $54,000
Q4 2020

Jan 27, 2021

SELL
$186.91 - $214.42 $4,298 - $4,931
-23 Reduced 10.09%
205 $42,000
Q3 2020

Nov 03, 2020

BUY
$167.03 - $201.3 $4,342 - $5,233
26 Added 12.87%
228 $43,000
Q2 2020

Jul 27, 2020

SELL
$113.31 - $182.44 $3,285 - $5,290
-29 Reduced 12.55%
202 $34,000
Q1 2020

Apr 22, 2020

BUY
$104.32 - $195.28 $11,788 - $22,066
113 Added 95.76%
231 $29,000
Q3 2019

Oct 31, 2019

BUY
$159.77 - $178.1 $1,118 - $1,246
7 Added 6.31%
118 $20,000
Q2 2019

Jul 24, 2019

BUY
$144.16 - $172.9 $2,018 - $2,420
14 Added 14.43%
111 $19,000
Q1 2019

Apr 23, 2019

BUY
$123.7 - $156.3 $5,813 - $7,346
47 Added 94.0%
97 $14,000
Q4 2018

Feb 07, 2019

BUY
$120.82 - $174.09 $6,041 - $8,704
50 New
50 $6,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.